F Salvo

Summary

Country: France

Publications

  1. doi A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France
    Francesco Salvo
    Departement de Pharmacologie, Université Bordeaux Segalen, INSERM U657, BP 36, 33076 Bordeaux, France
    Drug Saf 36:565-72. 2013
  2. doi Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials
    F Salvo
    Departement de Pharmacologie, Universite de Bordeaux, Bordeaux, France
    Clin Pharmacol Ther 89:855-66. 2011
  3. doi Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies
    F Salvo
    University of Bordeaux, INSERM U657, Bordeaux, France
    Clin Pharmacol Ther 99:306-14. 2016

Detail Information

Publications3

  1. doi A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France
    Francesco Salvo
    Departement de Pharmacologie, Université Bordeaux Segalen, INSERM U657, BP 36, 33076 Bordeaux, France
    Drug Saf 36:565-72. 2013
    ..However, a symmetrical event-competition bias has not yet been explored whereby known events may mask an association with new events for a given drug or drug class...
  2. doi Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials
    F Salvo
    Departement de Pharmacologie, Universite de Bordeaux, Bordeaux, France
    Clin Pharmacol Ther 89:855-66. 2011
    ..Our systematic review of MAs included information on the incidence of CV and GI events and identified important knowledge gaps regarding, in particular, the CV safety of traditional NSAIDs...
  3. doi Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies
    F Salvo
    University of Bordeaux, INSERM U657, Bordeaux, France
    Clin Pharmacol Ther 99:306-14. 2016
    ..01) accounted for 43% of this. The SCD/SUD risk differed between individual antipsychotics, and mean hERG blockade potency could be an explanatory factor. This should be considered when initiating antipsychotic treatment. ..